Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Interest & Investment Income (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Interest & Investment Income for 12 consecutive years, with $5.3 million as the latest value for Q1 2026.

  • For Q1 2026, Interest & Investment Income rose 84.03% year-over-year to $5.3 million; the TTM value through Mar 2026 reached $12.9 million, up 22.76%, while the annual FY2025 figure was $10.5 million, 3.1% up from the prior year.
  • Interest & Investment Income hit $5.3 million in Q1 2026 for Wave Life Sciences, up from $3.1 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $5.3 million in Q1 2026 and bottomed at $26000.0 in Q1 2022.
  • Average Interest & Investment Income over 5 years is $2.1 million, with a median of $2.1 million recorded in 2024.
  • Year-over-year, Interest & Investment Income soared 16400.0% in 2022 and then dropped 18.3% in 2025.
  • Wave Life Sciences' Interest & Investment Income stood at $825000.0 in 2022, then soared by 123.52% to $1.8 million in 2023, then surged by 102.71% to $3.7 million in 2024, then dropped by 18.3% to $3.1 million in 2025, then soared by 73.25% to $5.3 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $5.3 million, $3.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.